Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome
Conditions
- Polycystic Ovary Syndrome
Interventions
- DRUG: tredaptive (nicotinic acid/ laropiprant)
- DRUG: placebo
Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators